Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Study finishedNA

Human Skin Safety Testing of 1 Mitopure Topical Product Using a Clinical Safety in Use Study in Healthy Volunteers

Sponsor: Amazentis SA

NCT ID: NCT07517900

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Access to the study treatment being tested
Type of study
Interventional (receives a drug or procedure)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Mitopure Topical Formula (other)
How long the study runs
Study runs about 1 month (dates as stated)
About the drug or intervention
Mitopure Topical Formula — other: Topical skin serum containing Mitopure
Patient visit burden
Not specified by the sponsor
Type of study
Testing a treatment
Ages
18 Years and over
Who
All
Number of participants
40
Started
2026-04-20
Last checked
2026-06

Plain English Summary

What is this study?

  • • Testing a new treatment for healthy adult
  • • NA - 40 participants
  • • The objective of this study is to investigate the safety of 1 topically applied test article containing Mitopure in a panel of healthy volunteers

Who can take part?

  • • Ages 18 Years and over
  • • Diagnosed with healthy adult

Where?

  • • Manchester - PCR Corp

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

The objective of this study is to investigate the safety of 1 topically applied test article containing Mitopure in a panel of healthy volunteers.

Healthy Adult

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: 18 Years and over
  • Who can join: All genders

What the study is looking for

  • ✓Healthy male and female participants aged 18+.
  • ✓Participant has signed a written agreement to take part.
  • ✓Participant must agree to refrain from taking any new medications or herbal supplements during the study, unless...
  • ✓Participant does not have grade of 3 or higher of any skin attribute per the grading scale.
  • ✓Participant is willing to ONLY use the test article on themselves during the study as instructed and not use other...

Who cannot take part

  • ✗Participant is pregnant, nursing, or planning to become pregnant (by verbal response only).
  • ✗Participant has a current skin disease of any type (e.g., eczema, psoriasis, rosacea, atopic dermatitis, vitiligo).
  • ✗Participant has a known allergy to face serum products, or the ingredients included in the test article.
  • ✗Participant has a history of malignant disease.
  • ✗Participant has cuts, scratches, abrasions, rashes, scarring, birthmarks, or tattoos on their face that may...
See the full criteria
Inclusion Criteria: * Healthy male and female participants aged 18+. * Participant has signed a written Informed Consent. * Participant must agree to refrain from taking any new medications or herbal supplements during the study, unless permitted by the investigator. * Participant does not have grade of 3 or higher of any skin attribute per the grading scale. * Participant is willing to ONLY use the test article on themselves during the study as instructed and not use other facial serum products. * Participant is willing to attend all study visits and to follow the study instructions and prohibitions. * Participant must agree to refrain from using any new facial serum products, cleansers, laundry detergents, fragrances while participating in this study. Exclusion Criteria: * Participant is pregnant, nursing, or planning to become pregnant (by verbal response only). * Participant has a current skin disease of any type (e.g., eczema, psoriasis, rosacea, atopic dermatitis, vitiligo). * Participant has a known allergy to face serum products, or the ingredients included in the test article. * Participant has a history of malignant disease. * Participant has cuts, scratches, abrasions, rashes, scarring, birthmarks, or tattoos on their face that may interfere with assessments. * Participant has a significant past medical history of hepatic, renal, cardiac, pulmonary, digestive, haematological, neurological, locomotor or psychiatric disease. * Participant has a known sensitivity to the test article, similar materials, or their constituents. * Treatment or medication containing sympathomimetics, antihistamines or corticosteroids in the seven days prior to study start. * Medical condition that may affect study data or participant safety which in the opinion of the Investigator would compromise the safety of the participant or study results. * History of poor cooperation, non-compliance, or unreliability. * Investigator deems the participant an unsuitable candidate for the study.

Where Is This Study? (1 UK site)

PCR Corp

Manchester M13 0AF, United Kingdom

Data sourced from ClinicalTrials.gov · Last verified: 2026-06